Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and endothelium-dependent vasodilation
NL-OMON32503Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of bevacizumab in hypertension (HTN), sponsored by Radboud University Medical Center. Started Jun 2010; status: active, not recruiting.
02
Drugs
bevacizumab
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON32503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32503.